Royalty Report: Medical, Supply, Regenerative medicine – Collection: 288845


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Supply
  • Regenerative medicine
  • Tissue

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 288845

License Grant
The Licensor, a wholly owned subsidiary of an Israeli University and the Licensee agree that this Agreement shall supersede the License Agreement which is hereby terminated and shall have no further force and effect.   The original agreement was an exclusive worldwide license in Licensors patents and know-how to develop and commercialize products based on or incorporating coral-based conditioned medium for neuronal tissue regeneration and/or repair.
License Property
The services agreements related to laboratory access and other services.
Field of Use
The Field of Use shall mean treatments of traumatic brain injuries.

The Licensee received an exclusive worldwide royalty-bearing license in Licensor's patents and know-how to develop and commercialize products for neuronal tissue regeneration and/or repair, resulting from Licensor's research or technology or the Licensee's research funding.

IPSCIO Record ID: 183951

License Grant
The Israeli Licensor, a R&D business segment of a University, grants to the Licensee and/or its affiliates an exclusive, worldwide license, under Licensors rights in the Licensor Technology for the sole purpose of developing, manufacturing, using, offering for sale and selling the Products. The Company and its Affiliates shall be entitled to grant Sublicenses to third parties.
License Property
The technology is relating to coral based and non-coral based conditioned medium for tissue regeneration and repair.

62/443,826: Methods, compositions and devices related to neural cell development

Field of Use
This agreement is for the medical industry.

IPSCIO Record ID: 3101

License Grant
The Licensee has entered into multiple license agreements with three Universities.  Under the terms of the License Agreements, the Licensee acquired exclusive worldwide licenses for underlying technology used in repairing and regenerating nerves.

The licensed technologies include the rights to issued patents and patents pending in the United States and international markets.

License Property
Avance® Nerve Graft is a human tissue for transplantation.  Avance® Nerve Graft is processed nerve allograft (human) intended for the surgical repair of peripheral nerve discontinuities to support regeneration across the defect.

The AxoGuard® Nerve Protector is indicated for the repair of peripheral nerve injuries where there is no gap. The device is supplied sterile and is intended for one-time use.

Field of Use
The Licnesee is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.

In order to improve surgical reconstruction and regeneration of peripheral nerves, the Licensee has developed and licensed technologies, which are used in its products. Its product portfolio includes Avance® Nerve Graft which the Licensee believes is the first and only commercially available allograft nerve for bridging nerve discontinuities (a gap created when the nerve is severed) AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard® Nerve Protector, an implant that protects nerves during the body's healing process after surgery.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.